Introduction
The ability to transduce multiple genes into single cells will be advantageous in gene therapy especially where tight control over introduced genes is required or where multiple genetic defects need correction. Because retroviral vectors transduce and integrate into the genome for long-term expression, retroviral vectors have been developed to transduce multiple genes. Strategies for achieving retrovirus-mediated, multi-gene transduction include use of internal ribosomal entry sequences (IREs). [1] [2] [3] [4] The IRES vectors allow for the transduction of up to two genes simultaneously, in cis, on a single vector. Other retroviral vectors for transducing two genes into individual cells have contained internal promoters 1, 5, 6 to drive gene expression. While these retroviral vectors are effective in gene transduction, packaging constraints limit the number and size of inserts that the vectors may package and transduce. 6 Moreover, different combinations of genes and promoters may preclude packaging and effective gene transfer. 6 A solution to these constraints may be the cotransduction of independent virions into a single cell. Cotransduction would allow multiple genes of different sizes and combinations to be introduced into a single cell.
The apparent inability to cotransduce efficiently different virions into the same cell has been attributed to viral interference, 7 (ie the ability of one virus to inhibit the replication of a second virus in the same cell). Interference we demonstrate that by using two independent lentiviral vectors, pseudotyped with the protein g of vesicular stomatitis virus, up to four genes can be introduced simultaneously into single dividing and nondividing cells. Up to 45% and 73% of dividing and nondividing cells, respectively, could be transduced with two lentiviral vectors. The efficiency of cotransducing a single cell was the product of the individual transduction efficiencies and suggested the absence of viral interference. Multiple and combinatorial gene transduction using lentiviral vectors may prove useful in gene therapy. Gene Therapy (2000) 7, 1562-1569.
can occur between two dissimilar viruses such as human herpes virus 6 (HHV6) and HIV-1. 8 Homologous virus interference, on the other hand, occurs when viruses with similar genetic background infect the same cell. It has been established, for instance, that non-producer HIV-1 can repress the replication of an infectious isolate 9 via the use of defective gag, nef and vif 10 by presumably inhibiting packaging and budding of the otherwise infectious virus. Such interference can occur in the absence of receptor down-regulation. 11 However, the interference can also occur at the level of viral entry through receptor and coreceptor down-modulation 11 by one virus that prevents entry or re-entry of the second virus. 12 For the current studies, we reasoned that it should be possible to use at least two vectors to introduce multiple genes into the same cell. We noted, in particular, that during productive infection, the copy number of HIV-1 may exceed one 13, 14 implying that more than one copy of the virus, presumably isogenic, may integrate into the genome of the target cell. We noted also that receptor interference 7, 15 may be obviated by the use of virions pseudotyped with the vesicular stomatitis virus g protein (vsvg). On these bases, we hypothesized that HIV-1-based lentiviral vectors may be used successfully to cotransduce multiple genes into single cells. Here, we report the efficient cotransduction of up to four genes, encoded on two independent HIV-1 lentiviral vectors [16] [17] [18] [19] [20] [21] [22] into both single proliferating cells and post-mitotic cells.
Results

Cotransduction of proliferating cells
We set out to investigate whether two independent lentiviral vectors could be used to transduce simultaneously different genes into a single cell. We used lentiviral vectors expressing either cyan fluorescent protein (CFP) or yellow fluorescent protein (YFP) in these assays because the fluorescence spectra of the two proteins are non-overlapping and allow for simultaneous and multifactorial FACS analyses. Lentiviral vector constructs used in this study are shown in Figure 1 . In initial experiments, growing HeLa cells were transduced separately with either YFP-expressing or CFP-expressing virions (Figure 2a ). After transduction, these cells were trypsinized and cocultured to obtain a mixture of cyan and yellow-green fluorescent cells. Under these co-culture conditions, no cells were found to fluoresce cyan and yellow-green simultaneously, indicating that there was no observable fluorescence transfer between cells (Figure 2b cells that fluoresced yellow and cyan were observed (Figure 3a (iv) ). These dual-transduced cells constituted 29% of the gated cells and is similar to the predicted value of 21%, which is the product of the individual transduction efficiencies of 43% and 49% for CFP-and YFP-expressing virions, respectively, at the given MOI. 
(a) Transduction was done with either pHRcmvCFP virions (i), or pHRcmvYFP virions (ii) or both (iv). In (iii) equal numbers of cells from (i) and (ii) were mixed at the time of analyses. (b) Cotransductions were performed at different ratios of input virions. In (i) cells were transduced with pHRcmvCFP and pHRcmvYFP virions at MOI = 0.26 and MOI= 0.05, respectively. In (ii) and (iii) cotransductions were with CFP virions at MOI = 0.52 and YFP at MOI=0.05 (ii) and MOI=0.52 (iii). (c) Transduction efficiencies obtained with various multiplicities of infection.
The preceding results suggested that proliferating HeLa cells could be transduced with two different replication defective virions. Furthermore, there was no apparent virus interference between two different vsvgpseudotyped virions as confirmed by further experiments in which various YFP-and CFP-expressing replicationdefective viruses were cotransduced at different MOI ratios and the efficiencies of cotransduction were determined ( Figure 3b ). In all of these experiments we observed four populations of cells: untransduced, singly CFP-or YFP-transduced, and dual CFP-and YFP-transduced cells. Significantly, the proportion of doubly transduced cells was predictable in all the experiments irrespective of the ratios of transducing virions. As shown in Figure 3b (i), when growing HeLa cells were cotransduced with YFP virions (MOI = 0.05) and CFP virions (MOI = 0.26), 11% of the cells were found to be doublyfluorescent. The 11% cotransduction efficiency is comparable to the predicted value of 5% (the product of 12% and 43%, the respective efficiencies of YFP virions at MOI = 0.05 and of CFP virions at MOI = 0.26). A cotransduction of CFP virions (MOI = 0.52) and YFP virions (MOI = 0.05) yielded a cotransduction efficiency of 15% ( Figure  3b (ii)), comparable with the predicted value of 7.6% (the product of 12% and 63%, the efficiencies of YFP (MOI = 0.05) and CFP (MOI = 0.52), respectively). Cotransduction of each virion at MOI = 0.52 resulted in 45% of cells being cotransduced (Figure 3b (iii) ), similar to the predicted value of 43%.
Cotransduction of primary neurons and arrested HeLa cells
Since gene therapy applications may require the introduction of multiple genes into terminally differentiated primary cells, we investigated cotransduction into nondividing cells. We used aphidicolin-arrested HeLa cells and primary normal human neurons which have been shown to be refractory to non-lentiviral retroviral transduction. The aphidicolin-arrested HeLa cells were confirmed to be growth arrested by the inability of MLV-based GFPexpressing pBABEpuro vectors 23 to transduce these cells. At an MOI = 1, proliferating HeLa cells were transduced at 90% efficiency while the aphidicolin-treated cells were transduced at 2% efficiency (Figure 4a, middle panel) . Under the same transduction conditions, the HIV-1-based pHRcmvYFP virions transduced growing and aphidicolin-treated cells at 90% and 80% efficiencies, respectively (Figure 4a, lower panel) . Control transduced cells, using pHRcmvPuro virions resulted in 3% of the cells fluorescing green (Figure 4a, upper panel) . The neuronal cells were also confirmed to be post mitotic on account of the inability of the GFP-expressing pBABEpuro virions to transduce the cells (Figure 4b) .
Using the HIV-1-based vectors we found that the aphidicolin-arrested HeLa cells and the primary normal human neurons could be simultaneously cotransduced with CFP-and YFP-expressing lentiviral virions ( Figure  4c ) suggesting that both primary post-mitotic cells and drug-arrested cells are also receptive to the lentiviral vec- doubly fluorescent even higher than the predicted efficiency of 36% (Figure 5a (iv) ).
Significantly, the proportion of doubly transduced growth-arrested HeLa cells was predictable in further analyses irrespective of the ratios of transducing virions. When aphidicolin-treated HeLa cells were cotransduced with YFP virions (MOI = 0.05) and CFP virions (MOI = 0.26), 29% of the cells were found to be doubly fluorescent (Figure 5b (i) ). The 29% cotransduction efficiency is comparable with the predicted value of 15% (the product of 28% and 55%, the respective efficiencies of YFP virions at MOI = 0.05 and of CFP virions at MOI = 0.26, Figure 5c ). Cotransduction of CFP virions (MOI = 0.52) and YFP virions (MOI = 0.05) yielded a cotransduction
Figure 5 Efficiency of cotransduction into arrested HeLa cells. (a) Transduction with pHRcmvCFP (i), or pHRcmvYFP virions (ii) separately, or with both simultaneously (iv) in antibiotic-free media. In (iii) equal numbers of cells were mixed from (i) and (ii) before FACS analyses. (b) Arrested HeLa cells were cotransduced with pHRcmvCFP and pHRcmvYFP virions at different input ratios. In (i) cells were transduced with pHRcmvCFP and pHRcmvYFP virions at MOI = 0.26 and MOI = 0.05, respectively. In (ii) and (iii) cotransductions were with CFP virions at MOI = 0.52 and YFP at MOI = 0.05 (ii) and MOI = 0.52 (iii). (c) Transduction efficiencies obtained with various amounts of transducing particles.
efficiency of 37% (Figure 5b (ii)), comparable with the predicted value of 21% (the product of 28% and 75%, the efficiencies of YFP (MOI = 0.05) and CFP (MOI = 0.52), respectively). And, cotransduction of each virion at MOI = 0.52 resulted in 73% of cells being cotransduced ( Figure  5b (iii) ), similar to the predicted value of 62%.
Multivector gene transduction applied to Williams syndrome Diseases such as AIDS and cancers may require the introduction of therapeutic genes, possibly in diverse combinations, for effective therapy. As demonstrated above, cotransduction using lentiviral vectors may serve the purpose of introducing multiple correcting genes. We demonstrate this using the LIM Kinase 1 gene and its indirect substrate, actin. LIMK1 hemizygosity has been implicated as the cause of Williams syndrome, 24 a neurodegenerative condition marked by spatio-cognition defects. The kinase phosphorylates cofilin at Ser 3, inhibiting the activity of the latter and thereby reversing cofilin-induced actin depolymerization. 25 Actin aggregation, particularly at cell membranes, results from overexpressed LIMK activity.
To address the possible use of cotransduction to deliver up to four transgenes simultaneously into single cells, we subcloned cDNA encoding LIMK1 into pHRcmvBsd and yfpactin cDNA into pHRcmvPuro to create pHRcmvLIMK and pHRcmvYFPactin (Figure 1 ), respectively. These constructs would allow the simultaneous transduction of LIMK in cis with blasticidin-Sdeaminase gene, and of YFPactin in cis with puromycin-N-acetyltransferase gene. Replication defective virions of the two constructs were packaged and cotransduced into either HeLa cells or retinal pigment epithelial cells (RPEs). Control cells were cotransduced with pHRcmvPuro and pHRcmvBsd (Figure 1 ). Transduced cells were cultured in media supplemented with both puromycin and blasticidin and were assayed for actin aggregation by fluorescence microscopy. As shown in Figure 6 (left panels), the control cells comprised a single population of cells with normal and non-aggregated actin filaments. In contrast, cells cotransduced with LIMK1-and yfpactin-expressing virions contained a population of cells with highly aggregated actin ( Figure 6 , right panels). Actin aggregation is observed upon overexpression of active LIMK1 to phosphorylate cofilin and thereby inhibit the latter's activity. Our data therefore suggest that both LIMK1 and yfpactin transgenes were expressed in active forms and integrated into the endogenous pathway to exert their normal function. These imply that one can simultaneously transduce multiple structural and/or regulatory genes, acting at different points of a disease pathway, to control the expression and activities of either endogenous or cotransduced genes.
Discussion
The presence of genetic diseases having more than one genetic defect may necessitate the need to introduce more than one correcting gene into a single cell. Additionally, in cases where regulation is needed over transduced genes, a controlling gene together with the gene to be regulated must be introduced together into a single cell. Introduction of two or more genes into nondividing cells has hitherto involved the cloning of the two genes in cis on retroviral vectors. These genes are then packaged and transduced into cells. While the method is generally successful, there are limitations to the efficacy of the procedure. First, retroviral vectors impose an upper limit on the size of the gene insert. 6 The size limitation may preclude transduction of two relatively large genes on a single vector if the aggregate size exceeds the size of allowable inserts. Second, in some instances, promoter placement influences the efficiency of promoter strength. 5, 6 We reasoned that both problems may be solved by use of combinatorial and multiple independent lentiviral vectors for gene delivery into single cells.
Multi-vector gene transduction would allow the introduction of various combinations of genes for effective therapy. Dual-transduction had not been pursued, presumably because viral interference limits the efficacy of the method. 11, 12, 26 Under conditions of viral interference expression of any or all of the transgenes encoded on one virus is curtailed because a second virus inhibits expression of genes encoded on the first virus. The mechanism underlying the latter is unknown. We noted, however, that the copy number of HIV-1 may exceed one during productive infection. 13, 14 Proviruses are presumably isogenic when virus copy number exceeds one. Under productive infection conditions, viral gene expression occurs. Thus, we hypothesized that under high multiplicity of infection, multiple copies of near isogenic lentiviral vectors may be transduced into a single cell. Under these conditions, viral interference would be expected to be minimal or non-existent, particularly because superinfection of cells can result in gene expression encoded by the exogenous virus. 27, 28 If each provirus encodes a different transgene then co-expression of the genes in the same cell would be a test of multi-vector transduction. The stable expression of up to four transgenes, encoded on two independent proviruses, validates our hypotheses.
Gene Therapy
That the cotransduction efficiencies related directly to the individual transduction efficiencies confirmed the absence of viral interference as predicted.
Receptor interference imposes another block to coinfecting a single cell with two independent viruses. [29] [30] [31] This interference involves the ability of one virus to down-regulate the surface expression of an entry receptor or coreceptor utilized by a second virus. A potential superinfecting virus is thus thwarted by the receptor down-regulation. Thus, while sequential transductions can be used to deliver transgenes into single cells, 32 receptor interference apparently precludes the use of two amphotropic viruses to transduce single cells simultaneously. 7 Our use of vsvg-pseudotyped vectors derived from the documentation of Walker et al, 7 from the observation that vsvg-mediated entry is receptor independent, 33 and from our hypothesis that use of vsvg pseudotyping would allow simultaneous cotransduction into single cells. The vsvg pseudotyping was, therefore, a means to eliminate receptor interference. The finding in this work that there exists a direct relationship between cotransduction efficiency and the individual efficiencies confirms our hypothesis that vsvg pseudotyping would preclude receptor interference.
Our use of nearly isogenic attenuated HIV-1 proviral backbone in this study was meant to achieve another goal: to ensure that even if there were recombination the resulting provirus would be nonreplicating and multiply attenuated for infection since the transfer vector is both deleted and frameshifted in structural genes required for entry and for replication. 17, 19 Indeed, we detected no HIV-1 p24 antigen or replicating virus after extensive (2 month) selection of puromycin-and blasticidin-resistant Jurkat and HeLa cells that had been generated from cotransduction of both puromycin and blasticidin resistance-expressing virions (data not shown).
Gene regulation is an important objective of gene therapy. The results of our cotransducing LIMK and yfpactin illustrate the potential of cotransduction for regulatory purposes. LIMK1 regulates cofilin activity; cofilin in turn regulates actin polymerization. By phosphorylating cofilin on Ser3, LIMK1 indirectly regulates actin polymerization. The result here, that transduced LIMK1 causes cotransduced actin to aggregate, illustrates the use of multivector gene transduction to complete a regulatory loop via a functional endogenous gene. Importantly, while we cotransduced and coexpressed four genes (yfpactin, LIMK1, blasticidin-S-deaminase and puromycin-N-acetyltransferase) in HeLa and RPE cells, only two of the four transgenes (LIMK1 and yfpactin) are involved in the regulatory system. The blasticidin-S-deaminase and puromycin-N-acetyltransferase gene, cotransduced in cis with LIMK1 and yfpactin, respectively, can be replaced with other genes of interest to achieve even more elaborate transduced gene regulation.
Materials and methods
Vectors
Vectors pHRЈ, ⌬8.2 and pMDG have been previously described. 17, 22 pMDG expresses the vesicular stomatitis virus g protein (vsvg). Genes for cyan fluorescent protein (CFP) and for yellow fluorescent protein (YFP) were subcloned from pECFP-C1 and pEYFP-N1 (Clontech, Palo
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Alto, CA, USA), respectively, into pHRcmvNeo to create pHRcmvCFP and pHRcmvYFP (Figure 1 ). pHRcmvNeo was created by subcloning the PCR product of the pSV40-Neomycin fragment of pLXSN (Clontech) into the BamHI-XhoI sites of pHRcmvLacZ. 19 pHRcmvPuro was constructed by inserting the BamHI-ClaI fragment of pBabePuro 23 into BamHI-XhoI-digested pHRЈ. The BamHIClaI fragment of pBabePuro encodes the puromycin-Nacetyltransferase gene driven by the SV40 promoter. pHRcmvPuro is the backbone for vectors pHRcmvYPFmito and pHRcmvYFPactin (Figure 1 ). Mitochondrialocalized YFP (YFPmito) was derived from plasmid pcmvmycmitoyfp (Invitrogen, Carlsbad, CA, USA); yfptagged actin (yfpactin) was subcloned from vector pyfpactin (Clontech). pHRcmvBsd was constructed by inserting a BglII-SalI fragment of pSV40bsd, encoding SV40 promoter-driven blasticidin-S-deaminase gene, into pSHDR-HSA (address correspondence on vectors to K Frimpong). pSV40bsd is a derivative of pSV40zeo (Invitrogen) in which the zeocin cassette has been replaced with blasticidin-S-deaminase gene, the gene that confers resistance to blasticidin. pHRcmvBsd is the vector backbone for pHRcmvLIMK ( Figure 1) . The LIMK1 gene, encoding human LIM Kinase, was excised from pIND/GS (Invitrogen) backbone by a PmeI digest and was ligated into a SrfI-digested pHRcmvBsd.
Virus packaging
All virions were packaged in 293T cells using the method of Naldini et al with modifications. 16, 17 Briefly, 3 × 10 6 cells were plated on 100 mm plates in DMEM medium 24 h before packaging. Cells were then transfected with 40 g total of DNA using the calcium phosphate method. The transfected DNA consisted of 20 g transfer vector, 15 g packaging vector and 5 g of pMDG and was performed at 5% CO 2 , 37°C. Ten to 12 h after transfection, cells were washed and the medium was replaced with DMEM containing 50 mm Hepes buffer. Transfected cells were returned to 5% CO 2 , 37°C incubator for a further 24-36 h. Medium was then harvested, clarified by low speed centrifugation, filtered through 0.45 micron filters, aliquoted, and stored at −80°C until use. Viruses were titered on 5 × 10 4 growing HeLa cells plated per well of a four-well chamber slide for 24 h before infection. Cells were then transduced overnight with 500 l of 10-fold serial dilutions of virus in the presence of 4 g/ml polybrene. Cells were then washed in PBS and were cultured in DMEM for a further 48 h at 5% CO 2 , 37°C. After this period of incubation, the transduced cells were washed in PBS, fixed in 4% paraformaldehyde, and mounted for flourescence microscopy. Virus titer was determined as the number of counted fluorescent cells multiplied by 2 and by the appropriate dilution factor. Similar methods were used to determine the titer of pHRcmvBsd and pHRcmvPuro except that transduced cells were cultured for 7-10 days after transduction, and cells were assayed for live cells rather than for fluorescence. Titers for pHRcmvCFP, pHRcmvYFP, pHRcmvYFPmito were determined to be 1.0 × 10 5 , 1.1 × 10 5 and 1.6 × 10 5 infectious units/ml, respectively.
Neurons
Primary normal human neural progenitor cells were obtained from Clonetics (San Diego, CA, USA). The cells were plated and differentiated into post-mitotic neuronal cells 34, 35 according to the manufacturer's recommendations. Seven to 10 days after differentiation neurons were transduced using the appropriate quantities and types of virions, cell maintenance reagents and 4 g/ml polybrene. Transduction of neurons was conducted overnight at 37°C, 5% CO 2 . Cells were then washed and replenished with new neuronal medium for a further 72 h after which they were washed with PBS, fixed in 4% paraformaldehyde, and mounted for fluorescent photography.
Transduction of cells
For growing HeLa cells, 1 × 10 5 of cells were plated on tissue culture-treated 60 mm plates overnight at 37°C. These cells were transduced overnight in DMEM media in the presence of 4 g/ml polybrene and at 37°C, 5% CO 2 . To generate G1-S phase-arrested HeLa cells, 2 × 10 5 cells were first plated in 60 mm tissue culture plates at 37°C, 5% CO 2 incubator. Twenty-four hours later, the culture medium was replaced with DMEM containing 15 g/ml aphidicolin (Calbiochem, San Diego, CA, USA) for another 24 h to arrest the cells in G1. Using the appropriate amounts of packaged replication-defective virions, arrested cells were transduced with single or dual vectors in the presence of aphidicolin and 4 g/ml polybrene. Transduction was carried out overnight at 37°C and humidified CO 2 conditions. Cells were then washed, and the medium replaced with DMEM containing 15 g/ml aphidicolin. Forty-eight hours after transduction, cells were washed in PBS and fixed in 4% paraformaldehyde for fluorescent photography, or were washed, trypsinized and fixed for flow cytometry.
Fluorescence analyses
Flow cytometry was performed on a FACscan (Becton Dickinson, San Jose, CA, USA) at the Flow Cytometry Laboratory (Salk Institute, La Jolla, CA, USA). Unless otherwise stated, FACS analyses involved at least 10 000 gated cells. Fluorescence photography was conducted on a Nikon Optiphot microscope connected to a mercury arc lamp. All fluorescent filters were obtained from Omega Optical (Brattleboro, VT, USA).
